搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
labiotech
1 天
The future of epilepsy treatment: pioneering advances and patient-centric care
Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...
labiotech
1 天
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...
labiotech
2 天
Five biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug ...
Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...
labiotech
6 天
12 biotech unicorns revolutionizing the future of healthcare
Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...
labiotech
6 天
Second biotech IPO boom of the year: what does it mean for the industry?
Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...
labiotech
9 天
Spinal cord injury: Are we getting closer to a treatment?
Explore innovative treatments for spinal cord injury in clinical trials, including Lineage's OPC1 and NervGen's NVG-291, ...
labiotech
8 天
How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors
Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and leading to ...
labiotech
13 天
Six biotechs driving progress in Duchenne muscular dystrophy
Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.
labiotech
8 天
Top biotech deals of September 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.
labiotech
14 天
Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder
Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.
labiotech
13 天
Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.
labiotech
12 天
The biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈